• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见多因素眼病的代谢组学研究:年龄相关性黄斑变性、青光眼、糖尿病视网膜病变和近视生物标志物发现的综述

Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia.

作者信息

Belete Gizachew Tilahun, Zhou Lei, Li King-Kit, So Pui-Kin, Do Chi-Wai, Lam Thomas Chuen

机构信息

Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.

Research Centre for SHARP Vision (RCSV), The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.

出版信息

Front Mol Biosci. 2024 Aug 13;11:1403844. doi: 10.3389/fmolb.2024.1403844. eCollection 2024.

DOI:10.3389/fmolb.2024.1403844
PMID:39193222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11347317/
Abstract

INTRODUCTION

Multifactorial Eye disorders are a significant public health concern and have a huge impact on quality of life. The pathophysiological mechanisms underlying these eye disorders were not completely understood since functional and low-throughput biological tests were used. By identifying biomarkers linked to eye disorders, metabolomics enables early identification, tracking of the course of the disease, and personalized treatment.

METHODS

The electronic databases of PubMed, Scopus, PsycINFO, and Web of Science were searched for research related to Age-Related macular degeneration (AMD), glaucoma, myopia, and diabetic retinopathy (DR). The search was conducted in August 2023. The number of cases and controls, the study's design, the analytical methods used, and the results of the metabolomics analysis were all extracted. Using the QUADOMICS tool, the quality of the studies included was evaluated, and metabolic pathways were examined for distinct metabolic profiles. We used MetaboAnalyst 5.0 to undertake pathway analysis of differential metabolites.

RESULTS

Metabolomics studies included in this review consisted of 36 human studies (5 Age-related macular degeneration, 10 Glaucoma, 13 Diabetic retinopathy, and 8 Myopia). The most networked metabolites in AMD include glycine and adenosine monophosphate, while methionine, lysine, alanine, glyoxylic acid, and cysteine were identified in glaucoma. Furthermore, in myopia, glycerol, glutamic acid, pyruvic acid, glycine, cysteine, and oxoglutaric acid constituted significant metabolites, while glycerol, glutamic acid, lysine, citric acid, alanine, and serotonin are highly networked metabolites in cases of diabetic retinopathy. The common top metabolic pathways significantly enriched and associated with AMD, glaucoma, DR, and myopia were arginine and proline metabolism, methionine metabolism, glycine and serine metabolism, urea cycle metabolism, and purine metabolism

CONCLUSION

This review recapitulates potential metabolic biomarkers, networks and pathways in AMD, glaucoma, DR, and myopia, providing new clues to elucidate disease mechanisms and therapeutic targets. The emergence of advanced metabolomics techniques has significantly enhanced the capability of metabolic profiling and provides novel perspectives on the metabolism and underlying pathogenesis of these multifactorial eye conditions. The advancement of metabolomics is anticipated to foster a deeper comprehension of disease etiology, facilitate the identification of novel therapeutic targets, and usher in an era of personalized medicine in eye research.

摘要

引言

多因素眼病是一个重大的公共卫生问题,对生活质量有巨大影响。由于使用的是功能和通量较低的生物学检测方法,这些眼病背后的病理生理机制尚未完全明了。通过识别与眼病相关的生物标志物,代谢组学能够实现早期诊断、追踪疾病进程并进行个性化治疗。

方法

在PubMed、Scopus、PsycINFO和Web of Science等电子数据库中搜索与年龄相关性黄斑变性(AMD)、青光眼、近视和糖尿病视网膜病变(DR)相关的研究。检索于2023年8月进行。提取病例数和对照数、研究设计、使用的分析方法以及代谢组学分析结果。使用QUADOMICS工具评估纳入研究的质量,并检查代谢途径以确定不同的代谢谱。我们使用MetaboAnalyst 5.0对差异代谢物进行通路分析。

结果

本综述纳入的代谢组学研究包括36项人体研究(5项年龄相关性黄斑变性、10项青光眼、13项糖尿病视网膜病变和8项近视)。AMD中网络连接最多的代谢物包括甘氨酸和单磷酸腺苷,而青光眼患者中则鉴定出甲硫氨酸、赖氨酸、丙氨酸、乙醛酸和半胱氨酸。此外,在近视中,甘油、谷氨酸、丙酮酸、甘氨酸、半胱氨酸和氧代戊二酸是重要代谢物,而在糖尿病视网膜病变患者中,甘油、谷氨酸、赖氨酸、柠檬酸、丙氨酸和血清素是网络连接较多的代谢物。与AMD、青光眼、DR和近视显著富集并相关的常见顶级代谢途径是精氨酸和脯氨酸代谢、甲硫氨酸代谢、甘氨酸和丝氨酸代谢、尿素循环代谢以及嘌呤代谢。

结论

本综述概括了AMD、青光眼、DR和近视中潜在的代谢生物标志物、网络和途径,为阐明疾病机制和治疗靶点提供了新线索。先进代谢组学技术的出现显著增强了代谢谱分析能力,并为这些多因素眼病的代谢和潜在发病机制提供了新视角。预计代谢组学的进展将促进对疾病病因的更深入理解,有助于识别新的治疗靶点,并引领眼部研究进入个性化医学时代。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/50902f5e5bc9/fmolb-11-1403844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/71ee6f93fd1e/fmolb-11-1403844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/9586fc226361/fmolb-11-1403844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/c0794d8e9445/fmolb-11-1403844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/685027557889/fmolb-11-1403844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/8ae6bc62b043/fmolb-11-1403844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/50902f5e5bc9/fmolb-11-1403844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/71ee6f93fd1e/fmolb-11-1403844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/9586fc226361/fmolb-11-1403844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/c0794d8e9445/fmolb-11-1403844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/685027557889/fmolb-11-1403844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/8ae6bc62b043/fmolb-11-1403844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c569/11347317/50902f5e5bc9/fmolb-11-1403844-g006.jpg

相似文献

1
Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia.常见多因素眼病的代谢组学研究:年龄相关性黄斑变性、青光眼、糖尿病视网膜病变和近视生物标志物发现的综述
Front Mol Biosci. 2024 Aug 13;11:1403844. doi: 10.3389/fmolb.2024.1403844. eCollection 2024.
2
Metabolomics facilitates the discovery of metabolic profiles and pathways for myopia: A systematic review.代谢组学有助于发现近视的代谢特征和途径:系统评价。
Eye (Lond). 2023 Mar;37(4):670-677. doi: 10.1038/s41433-022-02019-0. Epub 2022 Mar 24.
3
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.血清非靶向代谢组学揭示亚洲人糖尿病视网膜病变进展的潜在生物标志物。
Front Mol Biosci. 2022 Jun 9;9:871291. doi: 10.3389/fmolb.2022.871291. eCollection 2022.
4
Metabolomics in Diabetic Retinopathy: A Systematic Review.代谢组学在糖尿病视网膜病变中的应用:系统评价。
Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):4. doi: 10.1167/iovs.62.10.4.
5
Metabolomics in Age-Related Macular Degeneration: A Systematic Review.代谢组学在年龄相关性黄斑变性中的应用:系统评价。
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):13. doi: 10.1167/iovs.61.14.13.
6
Positive and Negative Associations of Myopia with Ocular Diseases in Population-Based Studies.基于人群的研究中近视与眼部疾病的正相关性和负相关性。
Ophthalmology. 2024 Dec;131(12):1427-1435. doi: 10.1016/j.ophtha.2024.07.003. Epub 2024 Jul 5.
7
Differential associations of myopia with major age-related eye diseases: the Singapore Indian Eye Study.近视与主要年龄相关性眼病的关联差异:新加坡华人眼研究。
Ophthalmology. 2013 Feb;120(2):284-91. doi: 10.1016/j.ophtha.2012.07.065. Epub 2012 Oct 18.
8
Vitamin D and Ocular Diseases: A Systematic Review.维生素 D 与眼部疾病:系统评价
Int J Mol Sci. 2022 Apr 11;23(8):4226. doi: 10.3390/ijms23084226.
9
Metabolomics in Glaucoma: A Systematic Review.代谢组学在青光眼中的应用:系统评价。
Invest Ophthalmol Vis Sci. 2021 May 3;62(6):9. doi: 10.1167/iovs.62.6.9.
10
Metabolomics in serum of patients with non-advanced age-related macular degeneration reveals aberrations in the glutamine pathway.非老年相关性黄斑变性患者血清中的代谢组学研究揭示谷氨酰胺途径异常。
PLoS One. 2019 Jun 20;14(6):e0218457. doi: 10.1371/journal.pone.0218457. eCollection 2019.

本文引用的文献

1
Recent Advances and Perspectives in Relation to the Metabolomics-Based Study of Diabetic Retinopathy.基于代谢组学的糖尿病视网膜病变研究的最新进展与展望
Metabolites. 2023 Sep 12;13(9):1007. doi: 10.3390/metabo13091007.
2
Metabolomics in drug research and development: The recent advances in technologies and applications.药物研发中的代谢组学:技术与应用的最新进展
Acta Pharm Sin B. 2023 Aug;13(8):3238-3251. doi: 10.1016/j.apsb.2023.05.021. Epub 2023 May 23.
3
Integrating (Nutri-)Metabolomics into the One Health Tendency-The Key for Personalized Medicine Advancement.
将(营养)代谢组学融入“同一个健康”趋势——个性化医疗进步的关键
Metabolites. 2023 Jun 27;13(7):800. doi: 10.3390/metabo13070800.
4
Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank.三个美国队列和英国生物库中原发性开角型青光眼的血浆代谢物特征。
Nat Commun. 2023 May 19;14(1):2860. doi: 10.1038/s41467-023-38466-w.
5
Novel insights into the mechanisms of hard exudate in diabetic retinopathy: Findings of serum lipidomic and metabolomics profiling.糖尿病视网膜病变中硬性渗出物形成机制的新见解:血清脂质组学和代谢组学分析结果
Heliyon. 2023 Mar 31;9(4):e15123. doi: 10.1016/j.heliyon.2023.e15123. eCollection 2023 Apr.
6
Metabolomic analysis of aqueous humor reveals potential metabolite biomarkers for differential detection of macular edema.房水的代谢组学分析揭示了用于黄斑水肿鉴别检测的潜在代谢物生物标志物。
Eye Vis (Lond). 2023 Apr 1;10(1):14. doi: 10.1186/s40662-023-00331-8.
7
COMPLEMENT INHIBITION FOR GEOGRAPHIC ATROPHY: Review of Salient Functional Outcomes and Perspective.补体抑制治疗地图状萎缩:主要功能结局回顾与展望。
Retina. 2023 Jul 1;43(7):1064-1069. doi: 10.1097/IAE.0000000000003796.
8
New insight of metabolomics in ocular diseases in the context of 3P medicine.3P医学背景下代谢组学在眼部疾病中的新见解。
EPMA J. 2023 Feb 17;14(1):53-71. doi: 10.1007/s13167-023-00313-9. eCollection 2023 Mar.
9
Vitreous metabolomic signatures of pathological myopia with complications.病理性近视合并症的玻璃体代谢组学特征。
Eye (Lond). 2023 Oct;37(14):2987-2993. doi: 10.1038/s41433-023-02457-4. Epub 2023 Feb 25.
10
Machine Learning-Based Integration of Metabolomics Characterisation Predicts Progression of Myopic Retinopathy in Children and Adolescents.基于机器学习的代谢组学特征整合预测儿童和青少年近视性视网膜病变的进展
Metabolites. 2023 Feb 17;13(2):301. doi: 10.3390/metabo13020301.